GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (LTS:0R1D) » Definitions » Float Percentage Of Total Shares Outstanding

Sangamo Therapeutics (LTS:0R1D) Float Percentage Of Total Shares Outstanding : 99.43% (As of Jun. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sangamo Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sangamo Therapeutics's float shares is 206.32 Mil. Sangamo Therapeutics's total shares outstanding is 207.51 Mil. Sangamo Therapeutics's float percentage of total shares outstanding is 99.43%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sangamo Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sangamo Therapeutics's Institutional Ownership is 28.07%.

Sangamo Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Sangamo Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=206.32/207.51
=99.43%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sangamo Therapeutics (LTS:0R1D) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (LTS:0R1D) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
KPTI LIFE ACET ALLK SEER BSEM SCPH COYA CTXR CRVS OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
SGMO:USA GBY:Germany
Address
7000 Marina Boulevard, Brisbane, CA, USA, 94005
Website
https://www.sangamo.com
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Sangamo Therapeutics (LTS:0R1D) Headlines

No Headlines